Clinical Trial Update: Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating SPC1001 with monotherapy for essential hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypertension

Drugs mentioned

• SPC1001

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Hypertension, Essential Hypertension | Phase 2 | Status: COMPLETED